Home / Health / The Trillion-Dollar Gap in Women's Longevity Care
The Trillion-Dollar Gap in Women's Longevity Care
5 Sep
Summary
- Preventive health protocols often exclude midlife women's unique biology.
- The longevity industry is built on data predominantly from male cohorts.
- Addressing women's midlife health could add trillions to the global economy.
Preventive health protocols frequently overlook the distinct biological needs of women in their forties and beyond. Standard health panels often fail to capture the complex symptoms and hormonal transitions they experience, leaving a gap in care that is neither fully general wellness nor specific gynecology focused on reproductive years.
The longevity industry has largely relied on reference data and risk models derived from male and Western populations. This means a significant portion of the addressable market is served by protocols not designed for their specific biology. Femtech has proven women's health is a fundable category, but innovation has concentrated on fertility, leaving the high-value midlife-to-longevity window comparatively untouched.
Capturing this market requires building solutions around women's hormonal life stages from the outset, necessitating a "contextual memory" of their health trajectory. This contrasts with current fragmented health records. The next generation of longevity care will likely feature continuously updated patient profiles that interpret new signals against historical data, creating a robust "data moat."
Closing the women's health gap holds substantial economic promise, with estimates suggesting it could add nearly a trillion dollars annually to the global economy by 2040. Women aged 50 and above represented 26% of the global female population in 2021, a share that is rising, underscoring the growing importance of this demographic.
